http://www.news-medical.net/news/20110907/Breast-cancer-patients-with-BRCA1-mutation-experience-pCR-after-neoadjuvent-chemotherapy.aspx

“Nearly half of breast cancer patients carrying the BRCA1 mutation experience a complete pathological response (pCR) – the disappearance of all evidence of disease from the breast tissue and lymph nodes – regardless of disease stage after standard neoadjuvent chemo, according to new research from The University of Texas MD Anderson Cancer Center.”